Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Wolverine Stack Protocol Comparison — Dosing Strategies and Pathway Coordination

Aggressive Stack 10mg weekly 500mcg twice daily 10mg twice weekly All compounds dosed at upper limits simultaneously High receptor saturation risk. Likely to trigger GLP-1R downregulation within 3–4 weeks, reducing anti-inflammatory benefit Standard Stack 5mg

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Aggressive Stack
  • 10mg weekly
  • 500mcg twice daily
  • 10mg twice weekly
  • All compounds dosed at upper limits simultaneously
  • High receptor saturation risk. Likely to trigger GLP-1R downregulation within 3–4 weeks, reducing anti-inflammatory benefit
  • Standard Stack
  • 5mg weekly
  • 250mcg twice daily
  • 5mg twice weekly
  • Moderate doses with 24-hour offset between BPC-157 and TB-500
  • Balanced approach. Maintains pathway coordination while allowing dose titration based on response
  • Conservative Stack
  • 2.5mg weekly
  • 250mcg once daily
  • 2mg weekly
  • Low-end therapeutic doses with 48-hour spacing between all compounds
  • Lowest side effect risk but may require 10–12 weeks to see measurable tissue repair in chronic injury models
  • Sequential Stack
  • 5mg weekly (day 1)
  • 250mcg twice daily (day 2–6)
  • 5mg (day 3, day 6)
  • Tirzepatide → BPC-157 → TB-500 in deliberate sequence matching natural healing phases
  • Most pathway-specific coordination. Mimics natural wound healing cascade with anti-inflammatory phase preceding angiogenesis and remodeling
  • Maintenance Stack
  • 2.5mg every 10 days
  • 250mcg daily
  • Reduced dosing frequency after initial 8-week loading phase
  • Appropriate for sustained tissue quality improvement without chronic receptor saturation
  • The Sequential Stack variant produced the most consistent improvements in preclinical wound closure models because it respects the temporal order of biological healing: inflammation suppression → vascular infiltration → cellular migration → matrix remodeling. Dosing all compounds simultaneously compresses this timeline in a way that cells cannot physiologically accommodate.